In a Review now published online, Guilherme Harada, Soo-Ryum Yang, @emilianoCocco2 and @alexdrilon discuss some molecular subtypes of #lungcancer that, despite occurring in <5% of patients with this cancer type, affect a considerable number of individuals https://t.co/ECSkUEaqZR
🫁 Precision oncology starts with accurate HER2 testing in NSCLC. Strengthen your approach to identifying eligible patients, tailoring therapy, and collaborating across the multidisciplinary care team. 🔍 https://t.co/a9Matxc4kq
🔍 Accurate HER2 testing matters. 🧬 Explore targeted therapies for HER2-mutated NSCLC, 🩺 tailor treatment strategies to individual patients, and 🤝 engage multidisciplinary teams and patients in shared decision-making across the care continuum. ➡️ https://t.co/Tue1KRhgf3
When you FINALLY meet the mysterious molecular guy behind the microscope 🔬! @sooryumyang in the flesh! #nyl25@MSKCancerCenter@MSKPathology
THANK YOU for teaching me , understanding urgency & putting pts 1st 🥹 ( we were mid case discussion and paused for this selfie) 💁🏽♀️
Always great spending time with my friend & colleague @sooryumyang!
We discussed clinical strategies around c-MET IHC testing and what they mean for our patients.
Big thanks to @Pathologists for letting this medical oncologist join!
What should young patients ask about their lung cancer pathology?
Dr. @sooryumyang breaks it down at @cure_today’s FIRST Young-Onset Lung Cancer Summit.
Don’t miss it—join us! Register below👇🏽
https://t.co/h4V0GYSzkx
Join @tnewsomdavis, @sooryumyang, & me for @MedscapeOnc’s Live Event!
🎙️Educating, Empowering, & Engaging: A Focus on HER2-Activating Mutations in NSCLC
📅 Saturday, 2/22
⏰ 7–8 AM PT
📍 Hyatt Regency Huntington Beach
https://t.co/563WUcIeDi
One of the most popular webinars in our on-demand education catalog is about oncogenic RET fusions and features speaker @sooryumyang of @MSKCancerCenter. It's free for AMP members, $29 for nonmembers and offers continuing education credit: https://t.co/VvqCXob35y
Please join us tomorrow morning, November 13 at 11 am ET for the @ISIMMweb monthly webinar.
@sooryumyang from @MSKPathology is presenting "Predictive Immunohistochemical Biomarkers in NSCLC."
Register here: https://t.co/GFgFaLNJz9
Share widely!
Please vote for our case!! You know it’s a good case when you have a multidisciplinary collaboration between MD Anderson and Memorial Sloan Kettering! 🙏🏻🫁🧬💊🔬
Please join me and Dr. Jamie Chaft as we explore the latest updates in actionable biomarkers in early-stage NSCLC this Monday, September 9, 2024 at 12:30 PM PDT (Room: 33ABC) #WCLC24
Please join me and Dr. Jonathan Goldman as we discuss important updates in EGFR biomarker testing and treatment for advanced and early-stage NSCLC. @EGFRResisters@TheUSCAP
Application are open for the ‘26-‘27 #Cytopathology fellowship @MSKPathology.
We offer high volume exposure to diverse specimens, hands on training in US-guided FNA & dedicated research time
Learn more & apply @ ➡ https://t.co/6WDgjHF0Ty
DM me with ?? or for more info.
Today, we celebrate the anniversary of the monumental marriage equality ruling of Obergefell v. Hodges.
This case moved our country forward, and was made possible because of the courageous couples and advocates in the LGBTQI+ community who fought for these hard-won rights.
Please join me and Dr. Jonathan Goldman as we discuss important updates in EGFR biomarker testing and treatment for advanced and early-stage NSCLC. @EGFRResisters@TheUSCAP
🧬 Dive into the clinical implications of EGFR mutations in NSCLC. Learn to evaluate mutational status and use it to guide therapy plans. Enhance your diagnostic and treatment decisions through effective communication! 🎯 Join @sooryumyang & other experts: https://t.co/hGXkAp90pd
🚨It's Friday and time for another FDA approval!
👉FDA grants accelerated approval to adagrasib + cetuximab for KRAS G12C-mutated colorectal cancer #Precisionmedicine@SarahCannonDocs@bmsnews 🧬🎯
Link to FDA approval
https://t.co/tVLVR1F00s
Link to @NEJM
https://t.co/9k1lYwM0oL
Lighting tonight in partnership with @mskcancercenter in Honor of MSK’s 140th Anniversary and the ‘NYC for MSK’ Campaign
Text CONNECT to 274-16 to get alerts on our Lights!
Watch tonight's lighting here: https://t.co/O9J9aS1frk
📷: kingy27nyc/IG